CDER Review “Consistency” Is One Theme Of FDA Reorganization

FDA's decision to transfer most product reviews from the biologics center to CDER underscores the transformation in the images of the two centers during the user fee era

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet